Kodiak Sciences Inc

Stock Chart, Company Information, and Scan Results

$15.01(as of Sep 22, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Kodiak Sciences Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$15.01
Ticker SymbolKOD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees121
CountyUSA
Market Cap$503.4M
EBIDTA-188.9M
10-Day Moving Average10.12
P/E Ratio-3.96
20-Day Moving Average9.69
Forward P/E Ratio0.00
50-Day Moving Average8.52
Earnings per Share-3.79
200-Day Moving Average5.92
Profit Margin-Infinity%
RSI77.16
Shares Outstanding52.8M
ATR1.21
52-Week High16.30
Volume5,723,029
52-Week Low1.92
Most Recent Support Level9.10
Book Value70.3M
Most Recent Resistance Level9.93
P/B Ratio11.27
Upper Keltner12.40
P/S Ratio29.72
Lower Keltner6.97
Debt-to-Equity Ratio12.40
Next Earnings Date11/12/2025
Cash Surplus73.2M
Next Ex-Dividend DateUnknown

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Kodiak Sciences Inc In Our Stock Scanner

As of Sep 23, 2025
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.